
Xphyto Therapeutic

Hugh A. D. Rogers (President, CEO & Director)
Wolfgang Probst (Director)
Raimar Lobenberg (Independent Director)
Summary
History
Xphyto was founded in 2019 to explore the potential of cannabinoids and other natural compounds as effective therapeutic solutions. The company has since established a research division focused on the development and testing of biologically active agents. Xphyto is rapidly expanding its research capabilities, and is planning to launch several products later this year.
Mission
Vision
Key Team
Per S. Thoresen (Independent Director)
Peter Damouni (Director)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Hugh A. D. Rogers (President, CEO & Director)
Wolfgang Probst (Director)
Raimar Lobenberg (Independent Director)
